← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Evas Therapeutics, Llc.
Ballwin, MO
$1,985,748
Total funding
4
Grants
Funding over time
peak $727.2K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,985,748 · 4
By mechanism
R44$1,365,616 · 1
R43$620,132 · 3
Investigators at Evas Therapeutics, Llc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel antithrombotic agents to prevent hemodialysis vascular access failure$727,207
R44 · FY2012 · HL
Novel antithrombotic agents to prevent hemodialysis vascular access failure$638,409
R44 · FY2013 · HL
Cardioprotection by inhibition of coagulation and inflammation in myocardial infarction$299,999
R43 · FY2018 · HL
Pharmacologic treatment of thromboembolism$167,481
R43 · FY2009 · HL
Novel Recombinant Anticoagulant Proteins$152,652
R43 · FY2005 · HL